论文部分内容阅读
目的探讨腔内修复术(EVAR)治疗穿透性粥样硬化性主动脉溃疡(PAU)的预后。方法选取2010年11月—2015年6月宝鸡市中心医院收治的PAU患者131例,根据患者意愿分为对照组65例和观察组66例。对照组采用常规药物治疗,观察组采用EVAR治疗,比较两组患者近/远期预后。结果观察组患者手术均取得成功,发生切开不良2例(3.0%)。观察组患者近期肢体缺血、肾衰竭、新发主动脉夹层及主动脉破裂死亡发生率均低于对照组(P<0.05);远期肢体缺血、肾衰竭、新发主动脉夹层及主动脉破裂死亡发生率亦均低于对照组(P<0.05)。结论 EVAR治疗成功率较高,可改善PAU患者近/远期预后。
Objective To investigate the prognosis of penetrating atherosclerotic aortic ulcer (PAU) treated by endovascular repair (EVAR). Methods 131 patients with PAU admitted in Baoji Central Hospital from November 2010 to June 2015 were divided into control group (n = 65) and observation group (n = 66) according to their wishes. The control group was treated with conventional drugs. The observation group was treated with EVAR. The short-term and long-term prognosis of the two groups were compared. Results All the patients in the observation group were successful in surgery, and 2 cases (3.0%) had poor incision. The incidence of recent limb ischemia, renal failure, new aortic dissection and aortic rupture in the observation group were lower than those in the control group (P <0.05); limb ischemia, renal failure, new aortic dissection and the main Arterial rupture death rates were also lower than the control group (P <0.05). Conclusion The success rate of EVAR treatment is high, which can improve the short-term and long-term prognosis of patients with PAU.